HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $311,869 | -71.3% | 5,481 | -80.0% | 0.08% | -62.7% |
Q3 2022 | $1,086,000 | +90.9% | 27,459 | +112.3% | 0.22% | -5.2% |
Q2 2022 | $569,000 | -10.1% | 12,937 | -16.9% | 0.23% | +275.4% |
Q3 2021 | $633,000 | +213.4% | 15,566 | +228.5% | 0.06% | +32.6% |
Q1 2021 | $202,000 | 0.0% | 4,739 | 0.0% | 0.05% | 0.0% |
Q4 2020 | $202,000 | -36.7% | 4,739 | -61.0% | 0.05% | -33.3% |
Q3 2020 | $319,000 | +45.0% | 12,139 | +48.1% | 0.07% | -57.1% |
Q2 2020 | $220,000 | +3042.9% | 8,196 | +1539.2% | 0.16% | +2583.3% |
Q3 2015 | $7,000 | +250.0% | 500 | +400.0% | 0.01% | +200.0% |
Q2 2015 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |